baber/WOPTO huggingface dataset:
Patent JP-3842463-B2 (JP)
IPC: B60L50/16
Filed: 1998-11-20
Granted: 2006-11-08
Abstract: PROBLEM TO BE SOLVED: To ensure traveling to a goal in safety while limiting output to a drive wheel even upon occurrence of an abnormality in a power supply system as the drive system or the control system of a hybrid vehicle. SOLUTION: When a battery management system (a power supply system) is abnormal, control power supplies for first and second motors are turned off to stop the first and second motors (S222, S223). When the controllers for motor A and motor B are disconnected from a battery by turning a contactor off (S224), a state where normal control can be performed using respective abnormality control signals as normal signals is brought about (S225, S226). An engine is operated under torque control based on the output from an accelerator pedal sensor when a lockup clutch is turned on. A vehicle can be moved to a goal surely in safety while limiting the engine output by operating the engine at a low constant r.p.m. when the lockup clutch is turned off.
Patent JP-H0732796-B2 (JP)
IPC: A61F13/00
Filed: 1992-12-18
Abstract: The present invention provides a hydrogel wound dressing (30) substantially in the form of a rope and also in the form of a strand (31). The wound dressing (30) comprises a hydrogel material substantially in a rope configuration or a strand configuration (31) having a predetermined length for filling the cavity of a wound (W), and a dressing removal layer (32) disposed within the strand configuration (31). The dressing removal layer (32) may extend outwardly from an end (34) so as to form a pull tab (36) which facilitates removal of the rope configuration (31) from the wound (W). The present invention also provides a wound dressing (30) comprising a hydrogel material substantially in a strand configuration (31) having a predetermined length for filling the cavity of a wound (W). The strand configuration (31) also includes a dressing removal layer (32) disposed within the strand configuration (31) and may also include a pull tab (38) which facilitates removal of the strand configuration (31) from the wound (W).
Patent JP-3264877-B2 (JP)
IPC: C07D501/24
Filed: 1997-12-19
Granted: 2002-03-11
Abstract: The present invention relates to cephalosporin derivatives of the general formula <CHEM>  wherein   X   is CH or N; R<1>   is hydrogen or cyclopentyl; R<2>   is a group of formula <CHEM>   R<3>   is hydrogen, an alkalimetal ion or a tertiary ammonium group; R<4>   is hydrogen, an amino protecting group, pyrrolidin-2-ylmethyl, azetidin-3-ylmethyl, iminomethyl, 1-carbamimidoyl; R<5>   is hydrogen, dialkylcarbamoyl,  omega -hydroxyalkyl,  omega -aminoalkyl, pyridinium-1-ylmethyl, 1-hydroxy-3-aminomethyl-propyl or (hydroxy)-(pyrrolidin-2-yl)methyl; R<6>   is hydrogen, trifluoromethyl or hydroxy; and R<7>   is alkyl,  omega -hydroxy-alkyl, cycloalkyl, 3-pyrrolidinyl, 3-azetidinyl, iminomethyl or 1-carbamimidoyl; as well as readily hydrolyzable esters thereof, pharmaceutically acceptable salts of said compounds and hydrates of the compounds of formula I and of their esters and salts; the invention is further concerned with the manufacture of compounds of formula I; with their use as pharmaceutically active substances, particularly for the treatment and prophylaxis of infectious diseases, and with pharmaceutical preparations containing a compound of formula I for the treatment and prophylaxis of infectious diseases.
Patent JP-H0825796-B2 (JP)
IPC: C04B35/46
Filed: 1991-11-28
Abstract: A method of sintering an alkaline earth metal titanate, or a mixture thereof, which comprises the use as a sintering aid of a mixture of a mixed metal oxide of the formula BaCuO2 and at least one of tungsten trioxide or molybdenum trioxide.
Patent JP-H0767168-B2 (JP)
IPC: H04N7/088
Filed: 1987-10-08
Abstract: In a teletext system, in order to be able to "thumb through" the programme summaries of several days of transmission without making considerable investments in the teletext decoders on the recipient side, it is proposed to submit in the form of a tabulation on one separate page of teletext the page numbers of the total quantity of teletext pages in a repetition cycle or in a part of the latter, and to insert them in an intermediate memory on the recipient side. If the user has selected a precise teletext page, a check is made by comparing, with the page numbers inserted in the intermediate memory, whether the desired number of the teletext page figures in the cycle or in a part of the latter, after which said page is looked for if necessary. Furthermore, the decoder automatically checks on the basis of the number of the desired teletext page, and comparing again with the page numbers in the intermediate memory, whether the numbers of the following teletext pages figure in the cycle or in a part of the latter, after which a search is made for the following pages identified as figuring in said cycle, which are inserted in the intermediate memory and reproduced upon a special instruction from the user.
Patent JP-H0761964-B2 (JP)
IPC: C07C17/389
Filed: 1990-01-03
Abstract: R-1122 (2-chloro-1,1-difluoro-ethylene) can be substantially removed from a stream of R-134a over a zeolite or carbon molecular sieve having a mean pore size of about 3.8 to 4.8 Angstroms. Preferred are 5A synthetic zeolites or calcium chabazite.
Patent JP-3472300-B2 (JP)
IPC: C07D249/12
Filed: 1993-07-15
Granted: 2003-12-02
Abstract: A process for preparing tryptamine derivatives and related compounds having a 1,2,4-triazol-1-yl moiety within the molecule comprises reacting 4-amino-1,2,4-triazol with a nitrobenzene derivative containing a readily displaceable group; deaminating the aminotriazolium salt thereby obtained by treatment with nitrous acid followed by neutralisation; reducing the triazolyl-nitrobenzene derivative thereby obtained by transfer hydrogenation; treating the triazolyl-aniline derivative thereby obtained with nitrous acid and then with an alkali metal sulphate, followed by acidification; and subsequently reacting the triazolyl-hydrazine derivative thereby obtained in situ with a suitable carbonyl compound, to obtain the required triazolyl-indole derivative.
Patent JP-2752488-B2 (JP)
IPC: H04N7/30
Filed: 1989-04-14
Granted: 1998-05-18
Abstract: PCT No. PCT/FR89/00169 Sec. 371 Date Feb. 9, 1990 Sec. 102(e) Date Feb. 9, 1990 PCT Filed Apr. 14, 1989 PCT Pub. No. WO89/10042 PCT Pub. Date Oct. 19, 1989.The present invention relates to a method and apparatus of encoding and decoding blocks of data words. Each block has a fixed number of data words with a maximum of nbits, and a position of a data word within a block is diagonally identified by a series of absolute addresses having consecutive values. In the encoding of the data words of a block, the data words are classified into groups based on their most significant non-zero bit. Then the corresponding absolute address of each classified data word is encoded based on the absolute address of a previously encoded data word in the same class as the current classified data word and the number of data words encoded in classes less than the current classified data word since the previous encoding of a data word in the class of the current classified data word. Each data word with its ith and greater bits omitted is then transmitted along with the encoded absolute address. The encoded data words are decoded by determining the class of each encoded data word and storing, class by class, the encoded data words and their corresponding encoded addresses. The ith and greater bits of each encoded data words are reconstituted, and the encoded absolute addresses of each data word are then reconstituted into absolute addresses to reconstitute a block of data words.
Patent JP-3386124-B2 (JP)
IPC: A41B13/04
Filed: 1992-11-02
Granted: 2003-03-17
Abstract: A unitary disposable garment, such as disposable training pants, having a high degree of stretch in the cross-machine direction and fitting a broad range of wearer sizes. The unitary disposable garment is manufactured from a chassis and has a waist opening, two leg openings and a pair of side seams which join the front portion of the chassis to the rear portion of the chassis. The unitary disposable garment preferably has an absorbent assembly, i.e. an absorbent insert, secured to the inner layer of the chassis. The chassis from which the unitary disposable garment is manufactured, has four elasticized ear flaps; each ear flap is elasticized by securing an elastomeric element thereto and mechanically stretching the ear flap and the elastomeric element such that the ear flap is elastically extensible in the direction of initial stretching. The front portion of the chassis is then joined to the rear portion of the chassis on each side of the disposable garment by a seam.
Patent JP-3045773-B2 (JP)
IPC: B22D25/00
Filed: 1992-05-29
Granted: 2000-05-29
Abstract: A process and apparatus are described for manufacturing particle stabilized foamed metal slabs. A foam is first formed in a foaming chamber by heating a composite of a metal matrix and finely divided solid stabilizer particles above the solidus temperature of the metal matrix and discharging gas bubbles into the molten metal composite below the surface thereof to thereby form a stabilized liquid foam on the surface of the molten metal composite. The stabilized liquid foam is continuously drawn off the surface of the molten metal composite and is solidified into a shaped foam product while being continuously drawn off.
Patent JP-H0832787-B2 (JP)
IPC: C08L83/04
Filed: 1993-05-06
Abstract: New siloxane copolymers having vinyloxy groups contain: (a) siloxane units having the formula (I): Ra?Si(OR?1)b?O(4-(a+b))/2? , and (b) at least one unit per molecule selected from the grou p of units having the formulae (II), (III), (IV) or (V), in which R, R?1, Y, a, b, c, and x have the meaning given in the first claim.
Patent JP-4368943-B2 (JP)
IPC: C01B39/44
Filed: 1995-01-11
Granted: 2009-11-18
Abstract: PCT No. PCT/EP95/00103 Sec. 371 Date Dec. 19, 1996 Sec. 102(e) Date Dec. 19, 1996 PCT Filed Jan. 11, 1995 PCT Pub. No. WO95/21125 PCT Pub. Date Aug. 10, 1995Process for manufacturing an alkali metal aluminosilicate of zeolite wherein zeolite P seeds are produced in situ in a first reacting gel with a SiO2/Al2O3 ratio of above 2.2 and it is only after the formation of zeolite P seeds, but before said seeds have the time to fully grow, that sodium aluminate is added in order to get a gel which can have a SiO2/Al2O3 ratio of about 2 which therefore enables producing a zeolite P having also a SiO2/Al2O3 ratio of about 2.
Patent JP-3871705-B2 (JP)
IPC: C07D213/36
Filed: 1995-02-27
Granted: 2007-01-24
Abstract: A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.
Patent JP-3378585-B2 (JP)
IPC: G09F9/00
Filed: 1997-12-02
Granted: 2003-02-17
Abstract: A display with orientation dependent rotatably image presents a properly oriented image in a first mounted fold-down position and a second up-right table-top position. The display folds up into a base unit when not being used for compact storage of the system. An orientation determining device is included for determining the current orientation of the display and properly orienting the image based on that current orientation. The orientation determining device is either a mechanically flipped switch, an automatic switch or an acceleration sensor. The display screen is preferably an LCD screen. Alternatively, the display screen is a light valve type display including a grating light valve system. The display is for use in a television system, computer system, video phone or browser. Infrared input devices are used to control the display and provide data to the computer system. In an alternate embodiment, a touch sensitive screen is also used as an input device.
Patent JP-4234207-B2 (JP)
IPC: G01N33/68
Filed: 1997-12-19
Granted: 2009-03-04
Abstract: A method for the diagnosis of ABPA in a human individual, comprising determining if the individual carries antibodies reactive with one or more ABPA-related recombinant allergens.
Patent JP-4012575-B2 (JP)
IPC: A61P43/00
Filed: 1998-01-14
Granted: 2007-11-21
Abstract: A method for reducing or preventing the effects of inflammation arising from injured tissue, which method comprises the steps of:a. bringing the injured tissue, or pre-injured tissue, into contact with a photosensitizing agent capable of penetrating into the tissue, resulting in the desired degree of biodistribution in less than one hour; andb. exposing the tissue thus contacted to light having a wavelength absorbed by the photosensitizing agent for a time sufficient to reduce or prevent inflammation in the exposed tissue, but not so long as to cause necrosis or erythema of the exposed tissue,or a pharmaceutical composition or an article for reducing or preventing the effects of inflammation arising from injured tissue.The composition comprises:a. from about 1 mug/mL to about 2 mg/mL of a photosensitizing agent capable of penetrating into the injured tissue, or pre-injured tissue, resulting in the desired degree of biodistribution less than one hour; andb. a pharmaceutically acceptable carrier.The article comprises:a. a photosensitizing agent capable of penetrating into the injured tissue, or pre-injured tissue, resulting in the desired degree of biodistribution in less than one hour; andb. an absorbent applicator.
Patent JP-3130537-B2 (JP)
IPC: H04N9/30
Filed: 1996-05-23
Granted: 2001-01-31
Abstract: This invention provides a complementary color polarizer using a single polarizing film followed by a stack of two or more retarders. In a preferred embodiment, the color polarizers of this invention produce orthogonally polarized complementary primary colors (red/cyan, green/magenta, or blue/yellow). This invention further provides color filters which utilize the color polarizers of this invention in combination with a polarization separator to separate the orthogonally polarized colors. The polarization separator can be passive, such as a polarizing beam splitter, or active, such as a switchable polarizer. The switchable polarizer can employ a nematic or a smectic liquid crystal cell. Two color filters of this invention can be cascaded to provide a three color (RGB) filter with an off-state. In combination with a monochrome display or camera, the color filters of this invention provide color displays or cameras.
Patent JP-4189441-B2 (JP)
IPC: C03C4/00
Filed: 1998-03-06
Granted: 2008-12-03
Abstract: A synthetic quartz glass preform is produced by flame hydrolysis with subsequent cooling and is suitable for the application of high-energy DUV radiation in the wave length range under 250 nm. The preform has a core area which contains >=1150 ppm OH, a strain double refraction of <=5 nm/cm and a resistance to high-energy DUV radiation as a result of a transmission reduction of DeltaT <=0.1%/cm thickness. The quartz glass has been exposed to the following radiation: wavelength lambda<SUB>1</SUB>=248 nm, laser shot frequency >=300 Hz, laser shot value >=10<SUP>9 </SUP>and lumination <=10 MJ/CM<SUP>2</SUP>, and wavelength lambda<SUB>2</SUB>=193 nm, laser shot frequency >=300 Hz, laser shot value >=10<SUP>9 </SUP>and lumination <5 MJ/CM<SUP>2</SUP>. Apparatus for producing the preform comprises a horizontally positioned muffle with two different sized openings facing each other. The larger of the openings is for removing the preform, the smaller opening being for introducing a burner. The internal chamber of the muffle narrows from the larger opening to the smaller opening.
Patent JP-4459307-B2 (JP)
IPC: C07K14/78
Filed: 1998-03-20
Granted: 2010-04-28
Abstract: A method is disclosed for treating systemic lupus erythematosus in a mammalian subject, comprising administering to said subject an effective dose of at least one laminin peptide, or an analog or a derivative thereof. In one exemplary embodiment, the laminin peptide is selected from the group consisting of R38, and claimed R38 analogs and derivatives thereof including 5200, 5104, 5105, 5106, 5107, 5108, 5109, and 5110. The laminin peptides of the present invention may be prepared by known chemical synthetic methods or by biotechnological methods. Assays useful for the diagnosis of and following pathological activity course of systemic lupus erythematosus in patients suffering therefrom.
Patent PL-161595-B2 (PL)
Title: Thin film depositing apparatus
Inventor: MIERNIK KRZYSZTOF
IPC: C23C8/00
Filed: 1990-04-26
Abstract: 1. A device for deposition of films with the method of reactive ionic sublimation, consisting of a vacuum container, equipped with an inlet of working gas, outlet to the vacuum circuit and a crucible shaped as a nozzle, filled with material subject to vaporisation, characterised in that the crucible (7) is located inside the magnetic circuit (4) and connected to a negative end of high-voltage feeder (hv).<IMAGE>
Patent ES-2209564-B2 (ES)
Title: Procedimiento para la produccion de vidrios solubles y anhidrido sulfuroso mediante metodos termicos.
Inventor: GARCIA CARCEDO FERNANDO
IPC: C01B33/32
Filed: 2000-08-11
Granted: 2005-03-16
Abstract: Procedimiento para la producción de vidrios solubles y anhídrido sulfuroso mediante métodos térmicos. Comprende esencialmente la reacción de una fuente de sílice, una fuente de sulfato de sodio, un agente reductor y carbonato de sodio, en un horno de tipo balsa, de túnel o de Hoffmann, de baja turbulencia de gases, a una temperatura de 850-1500ºC, evacuándose por una parte el vidrio fundido obtenido y, por otra, los gases producidos a partir de los cuales se recupera el anhídrido sulfuroso en forma líquida o gaseosa. Aplicación en los sectores técnicos del vidrio soluble y del anhídrido sulfuro y sus diferentes usos en muy variados campos de la industria.
Patent ES-2380534-B2 (ES)
Title: Sistema de prolongacion de la vida de las turbinas de plantas termosolares
Inventor: ROVIRA DE ANTONIO ANTONIO
IPC: F01K23/02
Filed: 2009-07-17
Granted: 2012-09-14
Abstract: Sistema que comprende un circuito hidráulico (1, 28, 32) que contiene y conecta:#- al menos un cuerpo de la turbina (4, 35);#- un turbocompresor (12, 44) que comprime parte o la totalidad del fluido de trabajo;#- unos ramales (8, 11, 15 ,19, 33, 39) por los que circula fluido de trabajo;#- intercambiadores de calor (20, 29, 41, 47);#- un depósito (16) que contiene fluido de trabajo en estado líquido;#- un refrigerador, que puede coincidir con el foco frío (23) de la central;#- válvulas de corte (3, 7 ,9, 22, 34, 38, 40, 49), de regulación (18, 52), divisores (10) y bombas (17, 24, 25, 51) en el circuito hidráulico y en los diversos ramales.#El sistema actúa para que, durante la parada de la central, la turbina trabaje en una carga de consigna y no sufra pérdida de vida por fatiga.
Patent ES-2518065-B2 (ES)
Title: Sensor para la determinación de la profundidad y velocidad de carbonatación del hormigón
Inventor: GANDIA ROMERO JOSÉ MANUEL
IPC: G01N33/38
Filed: 2014-09-19
Granted: 2015-02-18
Abstract: Sensor para la determinación de la profundidad y velocidad de carbonatación del hormigón.#La presente invención se refiere a un sensor de pH que comprende: una pista de un conductor eléctrico; sobre la pista de conductor eléctrico, un óxido metálico de al menos un metal M, donde M es un metal que presenta al menos dos estados de oxidación, donde el potencial de reducción entre dichos estados de oxidación varía con el pH; una capa de material dieléctrico que cubre parcialmente la pista del conductor eléctrico; y medios para conexión eléctrica; caracterizado porque M no forma especies solubles a pH > 7; y porque el óxido metálico está recubierto de un polímero hidrogel.
Patent AU-2001238038-B2 (AU)
Title: Implantable vascular device
Inventor: OBERMILLER JOSEPH F
IPC: A61B17/12
Filed: 2001-02-05
Granted: 2005-08-25
Abstract: A multiple-sided valve for implantation within a body vessel comprising a frame comprising a bioabsorbable material is provided. The devices can be pushed from a delivery catheter into the lumen of a duct or vessel and may include one or more barbs for anchoring purposes. A full or partial covering of fabric or other flexible material, or a bioabsorbable material, including a collagen-based material such as small intestinal submucosa (SIS), may be attached to the frame to form an occlusion device, a graft, or an implantable, intraluminal valve such as for correcting incompetent veins in the lower legs and feet.
Patent AU-2001252272-B2 (AU)
Title: Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
Inventor: SEIDELMANN DIETER
IPC: A61P27/06
Filed: 2001-04-24
Granted: 2007-03-29
Abstract: N-Substituted benzamide derivatives (I) are new. Also new are methyl benzoate derivative intermediates (II). N-Substituted benzamide derivatives (I) (including thioamide, amine and amidine analogs) are new. [Image] W : O, S, H 2 or NR 8; Z 1>a direct bond, =NR 10, =N-, optionally branched 1-12C alkyl or -(CR aR b) m-(CR cR d) n-(CR eR f) o-; m, n, o : 0-3; R a-R fH, F, 1-4C alkyl or =NR 10; or R a + R c and/or R d + R ea bond; or 1 or 2 of R a-R fupto 3C bridge with R 1 or R 7; R 1alkyl, 2-12C alkenyl, 3-12C alkynyl, 3-10C cycloalkyl or 3-10C cycloalkenyl (all optionally substituted by at least one of halo and alkyl), or aryl or heteroaryl (both optionally substituted by one or more of halo, alkyl, 1-alkoxy, mono- or polyhaloalkyl and mono- or polyhaloalkoxy); R 2, R 3H, OH or XR 11; X : 2-6C alkyl, 2-6C alkenyl or 2-6C alkynyl; R 11mono- or bicyclic aryl or heteroaryl (all os by one or more of halo, alkyl, alkoxy or OH); R 4-R 6H or halo; or alkoxy, alkyl or carboxyalkyl (all optionally substituted by one or more halo), or R 4 + R 5methylenedioxy; R 7H or alkyl, or forms an up to 3C bridge with R a-R f or R 1; R 8, R 10H or alkyl; alkyl moieties have 1-6C unless specified otherwise; provided that: (i) R 2/R 3 are not H/H, H/OH or OH/H and (ii) R 1 = is not triazole. An independent claim is included for new methyl benzoate derivative intermediates of formula (II) and their isomers and salts. [Image] R 2', R 3'H or XR 11', but not both H, and R 11'phenyl or pyridyl (both optionally substituted by alkyl). - ACTIVITY : Cytostatic; antipsoriatic; antirheumatic; antiarthritic; ophthalmological; antidiabetic; nephrotropic; immunosuppressive; antiinflammatory; hepatotropic; antiarteriosclerotic; neuroprotective. - MECHANISM OF ACTION : Tyrosine kinase KDR inhibitor; tyrosine kinase FLT inhibitor; vascular endothelial growth factor (VEGF) receptor phosphorylation inhibitor. N-(4-n-propylphenyl)-2-(4-pyridylethyl)-benzamide (Ia) exhibited an IC 50 value 0.2 mu M for inhibition of both tyrosine kinases KDR and FLT.